Johnson & Johnson (NYSE:JNJ) was the target of unusually large options trading activity on Wednesday. Traders acquired 1,957 call options on the company. This is an increase of 194% compared to the typical daily volume of 665 call options.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Lenox Wealth Advisors Inc. raised its position in Johnson & Johnson by 0.7% in the first quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock valued at $108,000 after buying an additional 6 shares in the last quarter. Landmark Financial Advisors LLC raised its position in Johnson & Johnson by 0.4% in the first quarter. Landmark Financial Advisors LLC now owns 1,955 shares of the company’s stock valued at $244,000 after buying an additional 7 shares in the last quarter. Lbmc Investment Advisors LLC raised its position in Johnson & Johnson by 0.4% in the first quarter. Lbmc Investment Advisors LLC now owns 3,704 shares of the company’s stock valued at $461,000 after buying an additional 14 shares in the last quarter. Berson & Corrado Investment Advisors LLC raised its position in Johnson & Johnson by 0.7% in the first quarter. Berson & Corrado Investment Advisors LLC now owns 2,835 shares of the company’s stock valued at $353,000 after buying an additional 19 shares in the last quarter. Finally, Westside Investment Management Inc. raised its position in Johnson & Johnson by 0.7% in the first quarter. Westside Investment Management Inc. now owns 3,102 shares of the company’s stock valued at $387,000 after buying an additional 21 shares in the last quarter. Institutional investors own 65.30% of the company’s stock.

A number of research firms have recently weighed in on JNJ. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $132.33 price target on the stock in a research note on Thursday, May 18th. Stifel Nicolaus reaffirmed a “hold” rating and issued a $128.00 price target (up from $124.00) on shares of Johnson & Johnson in a research note on Thursday, May 18th. Barclays PLC reissued an “equal weight” rating and set a $130.00 target price (up from $125.00) on shares of Johnson & Johnson in a research report on Monday, April 17th. JPMorgan Chase & Co. raised shares of Johnson & Johnson from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $123.64 to $140.00 in a research report on Monday, May 15th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $135.00 target price (down from $140.00) on shares of Johnson & Johnson in a research report on Sunday, May 14th. Eleven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $130.90.

Johnson & Johnson (NYSE:JNJ) traded up 0.90% during midday trading on Wednesday, hitting $128.25. 3,452,799 shares of the company traded hands. The stock’s 50-day moving average price is $124.63 and its 200 day moving average price is $119.74. The company has a market capitalization of $345.48 billion, a price-to-earnings ratio of 21.56 and a beta of 0.74. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $129.00.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, April 18th. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.77 by $0.06. The company had revenue of $17.77 billion for the quarter, compared to analyst estimates of $18.02 billion. Johnson & Johnson had a net margin of 22.78% and a return on equity of 25.61%. Johnson & Johnson’s revenue for the quarter was up 1.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.68 EPS. On average, equities analysts forecast that Johnson & Johnson will post $7.11 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 13th. Stockholders of record on Tuesday, May 30th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Thursday, May 25th. This is a positive change from Johnson & Johnson’s previous quarterly dividend of $0.80. This represents a $3.36 annualized dividend and a dividend yield of 2.64%. Johnson & Johnson’s payout ratio is currently 54.42%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.americanbankingnews.com/2017/05/31/stock-traders-buy-high-volume-of-call-options-on-johnson-johnson-jnj.html.

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.